Digital Health is part of our work in Communications, Consumer Goods and Services, Electronics and Information Technology, and Life Sciences.
Finnegan helps clients—from startups to established companies—with developing IP strategies to protect their innovative solutions directed to digital health technologies intended to drive down costs while improving patient care. Consumers have access to an ever-growing number of affordable and portable devices designed to provide metrics and details about personal health and lifestyle. In an increasingly connected world, this type of information can be invaluable in helping healthcare professionals provide higher levels of care. We also see drug makers partnering with digital health companies at record rates. The multi-faceted market of digital therapeutics has the promise of supplementing or even replacing traditional clinical therapy. As modern medicine grows in complexity and moves beyond the capacity of human retention—there are thousands of diagnoses, drugs, and medical and surgical procedures available today—digital health technologies provide the necessary tools to advance the level of patient care and service.
Finnegan’s attorneys work with companies to develop IP strategies from holistic viewpoint, ensuring a true convergence of technical innovation. Our technical experience spans the life sciences (biotechnology, clinical, diagnostics, healthcare, pharmaceuticals, genomics, bioinformatics, medical devices), across computer and software technologies such as artificial intelligence, big data, and cloud storage, to industrial manufacturing, nanotechnology, sensors, and other related fields. We understand the legal nuances corresponding to these various technologies, as certain types of technologies can be more sensitive than others when it comes to specific legal aspects, so we work closely with clients to develop appropriate strategies for acquiring IP protection based on their core business goals, development speed, ease of market entry, market fluidity, changing alliances, ease of copying, and ease of enforcement. We also evaluate current industry trends, pending legislation and case law, potential product and industry developments, and the effect of those developments on our clients’ IP position. We counsel established companies innovating in intersecting industries to properly capitalize on opportunities that promote and align values across its various brands. We then advise on how best to protect and leverage their innovations through patents, trademarks, copyrights, and trade secrets, and we guide them around the barriers created by others.
As we engage with digital health innovators pushing boundaries and creating new markets, we help by:
1:16-cv-00146, D. Del., Judge Robinson
Apple Eyes Long-Term Software Fix for Watch While Appealing Ban
December 28, 2023
Press Release
Finnegan Celebrates Two Wins at the 2020 LMG Life Sciences Awards and Top Honors in the Rankings
October 5, 2020
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.